Deus Cielo

1.1k total citations · 1 hit paper
21 papers, 592 citations indexed

About

Deus Cielo is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Epidemiology. According to data from OpenAlex, Deus Cielo has authored 21 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Deus Cielo's work include Brain Metastases and Treatment (15 papers), Glioma Diagnosis and Treatment (14 papers) and Meningioma and schwannoma management (5 papers). Deus Cielo is often cited by papers focused on Brain Metastases and Treatment (15 papers), Glioma Diagnosis and Treatment (14 papers) and Meningioma and schwannoma management (5 papers). Deus Cielo collaborates with scholars based in United States. Deus Cielo's co-authors include Adetokunbo A. Oyelese, John H. Shin, Oliver Y. Tang, Ian D. Connolly, Patricia L. Zadnik Sullivan, Albert E. Telfeian, Ziya L. Gokaslan, Jared Fridley, Rohaid Ali and Curtis E. Doberstein and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Neurosurgery.

In The Last Decade

Deus Cielo

20 papers receiving 581 citations

Hit Papers

Performance of ChatGPT, GPT-4, and Google Bard on a Neuro... 2023 2026 2024 2025 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deus Cielo United States 11 292 183 173 149 90 21 592
Antonio Yaghy United States 13 77 0.3× 132 0.7× 36 0.2× 14 0.1× 27 0.3× 58 495
Anna Rotili Italy 15 98 0.3× 420 2.3× 109 0.6× 6 0.0× 167 1.9× 47 723
Chen‐Fei Wu China 11 55 0.2× 111 0.6× 107 0.6× 10 0.1× 58 0.6× 19 533
Enoch Chang United States 9 33 0.1× 98 0.5× 120 0.7× 88 0.6× 24 0.3× 27 478
Giorgio Maria Agazzi Italy 13 34 0.1× 343 1.9× 152 0.9× 26 0.2× 89 1.0× 24 477
H.P. Bagshaw United States 13 14 0.0× 208 1.1× 210 1.2× 61 0.4× 29 0.3× 48 526
Alifia Hasan United States 7 44 0.2× 67 0.4× 73 0.4× 38 0.3× 9 0.1× 11 343
Akhil Muthigi United States 14 51 0.2× 177 1.0× 499 2.9× 8 0.1× 29 0.3× 46 708
Jennifer Shah United States 12 15 0.1× 173 0.9× 169 1.0× 35 0.2× 40 0.4× 48 557
Sonja Stieb Switzerland 15 16 0.1× 399 2.2× 265 1.5× 33 0.2× 57 0.6× 43 650

Countries citing papers authored by Deus Cielo

Since Specialization
Citations

This map shows the geographic impact of Deus Cielo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deus Cielo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deus Cielo more than expected).

Fields of papers citing papers by Deus Cielo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deus Cielo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deus Cielo. The network helps show where Deus Cielo may publish in the future.

Co-authorship network of co-authors of Deus Cielo

This figure shows the co-authorship network connecting the top 25 collaborators of Deus Cielo. A scholar is included among the top collaborators of Deus Cielo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deus Cielo. Deus Cielo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Rohaid, Oliver Y. Tang, Ian D. Connolly, et al.. (2023). Performance of ChatGPT, GPT-4, and Google Bard on a Neurosurgery Oral Boards Preparation Question Bank. Neurosurgery. 93(5). 1090–1098. 215 indexed citations breakdown →
2.
Ali, Rohaid, Oliver Y. Tang, Ian D. Connolly, et al.. (2023). Performance of ChatGPT and GPT-4 on Neurosurgery Written Board Examinations. Neurosurgery. 93(6). 1353–1365. 131 indexed citations
3.
Sastry, Rahul A., et al.. (2022). Incidence, Characteristics, and Outcomes of Pseudomeningocele and Cerebrospinal Fluid Fistula after Posterior Fossa Surgery. World Neurosurgery. 164. e1094–e1102. 8 indexed citations
4.
Elinzano, Heinrich, et al.. (2020). Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma. American Journal of Clinical Oncology. 44(2). 49–52. 18 indexed citations
5.
Elinzano, Heinrich, et al.. (2020). Nanoliposomal irinotecan and metronomic temozolomide for patients with recurrent glioblastoma: BrUOG329, a phase IB/IIA Brown University Oncology Research Group (BrUOG) trial.. Journal of Clinical Oncology. 38(15_suppl). e14548–e14548. 1 indexed citations
6.
Katipally, Rohan, Paul Rava, Deus Cielo, et al.. (2017). Surgical Resection and Posterior Fossa Location Increase the Incidence of Leptomeningeal Disease in Patients Treated with Stereotactic Radiosurgery for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 99(2). S173–S173. 4 indexed citations
7.
Chan, Jason W., Paul Rava, Daniel Gorovets, et al.. (2017). Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases. World Neurosurgery. 104. 589–593. 49 indexed citations
8.
Sindhu, Kunal K., Sohail Syed, & Deus Cielo. (2017). The Role of Radiation Therapy in the Treatment of Metastatic Brain Disease.. PubMed. 100(6). 21–24. 1 indexed citations
9.
Rae, Ali I., Daniel Gorovets, Paul Rava, et al.. (2016). Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis. Advances in Radiation Oncology. 1(4). 294–299. 15 indexed citations
10.
Ebner, Daniel K., Daniel Gorovets, Paul Rava, et al.. (2016). Patients with Long-Term Control of Systemic Disease Are a Favorable Prognostic Group for Treatment of Brain Metastases with Stereotactic Radiosurgery Alone. World Neurosurgery. 98. 266–272. 7 indexed citations
11.
Gorovets, Daniel, D.N. Ayala-Peacock, David J. Tybor, et al.. (2016). Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 97(2). 246–253. 28 indexed citations
12.
Gorovets, Daniel, Paul Rava, Daniel K. Ebner, et al.. (2015). Predictors for Long-Term Survival Free from Whole Brain Radiation Therapy in Patients Treated with Radiosurgery for Limited Brain Metastases. Frontiers in Oncology. 5. 110–110. 15 indexed citations
13.
Ebner, Daniel K., Paul Rava, Daniel Gorovets, Deus Cielo, & Jaroslaw T. Hepel. (2015). Stereotactic radiosurgery for large brain metastases. Journal of Clinical Neuroscience. 22(10). 1650–1654. 28 indexed citations
14.
Rae, Ali I., Daniel Gorovets, Paul Rava, et al.. (2015). Management Approach for Recurrent Brain Metastases Following Upfront Radiosurgery May Affect Risk of Subsequent Radiation Necrosis. International Journal of Radiation Oncology*Biology*Physics. 93(3). E78–E78.
15.
Gorovets, Daniel, Daniel K. Ebner, Paul Rava, et al.. (2014). Improving Patient Selection for Stereotactic Radiosurgery as the Initial Radiation Therapy Approach for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 90(1). S320–S320. 1 indexed citations
16.
Jeyapalan, Suriya, Jerrold L. Boxerman, John E. Donahue, et al.. (2013). Paclitaxel Poliglumex, Temozolomide, and Radiation for Newly Diagnosed High-grade Glioma. American Journal of Clinical Oncology. 37(5). 444–449. 40 indexed citations
17.
Rava, Paul, Thomas A. DiPetrillo, I Mihaylov, et al.. (2013). Factors Influencing Local Control and Survival in Patients Treated With Radiosurgery Following Surgical Resection of CNS Metastases. International Journal of Radiation Oncology*Biology*Physics. 87(2). S161–S161. 1 indexed citations
18.
Jeyapalan, Suriya, John E. Donahue, Heinrich Elinzano, et al.. (2011). A phase II study of paclitaxel poliglumex (PPX), temozolamide (TMZ), and radiation (RT) for newly diagnosed high-grade gliomas.. Journal of Clinical Oncology. 29(15_suppl). 2036–2036. 6 indexed citations
19.
Alvarez, Victor E., et al.. (2009). Intracranial collision metastases of prostate and esophageal carcinoma. Journal of Neuro-Oncology. 95(1). 147–150. 11 indexed citations
20.
Cielo, Deus, et al.. (2009). Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma. Journal of Oncology. 2009. 1–11. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026